Found 567 matching trials
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) PHASE1 GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line PHASE2 In second line with advanced or recurrent biliary tract cancer refractory t...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX PHASE3 The aim of this adaptive Phase 3 trial is to show a statistically significa...
Show More Location
Compassionate Cancer Care Medical Group, Inc
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) PHASE2 This clinical study is in subjects who are 18 years old or older with local...
Show More Location
Mayo Clinic - Arizona
Learn More & Join Trial
Combination Chemotherapy In Treating Patients With Advanced Cancer PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of combina...
Show More Location
Asan Medical Center
Learn More & Join Trial
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma PHASE2 The aim of the study is to assess if gemcitabine in combination with carbop...
Show More Location
Loh Guan Lye Specialist Centre
Learn More & Join Trial